Non-oncologic Indications for Male Fertility Preservation
Purpose of Review
To explore non-oncologic indications for male fertility preservation.
Common scenarios in which male fertility could be irreversibly compromised include autoimmune conditions requiring treatment with cyclophosphamide, gender dysphoria prior to starting hormone therapy, military deployment, and critical illness. Fertility preservation should be considered with particular attention to the timing and logistics specific to each scenario.
Recognition and familiarity with such situations will help physicians provide better counseling to patients and their families, improve the quality of decision-making, and ultimately reduce missed opportunities and regret.
KeywordsMale fertility preservation Cyclophosphamide Gender dysphoria Postmortem sperm retrieval Military deployment
Compliance with Ethical Standards
Conflict of Interest
Heiko Yang, Joris Ramstein, and James Smith each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 8.• Glen CD, Dubrova YE. Exposure to anticancer drugs can result in transgenerational genomic instability in mice. Proc Natl Acad Sci U S A. 2012;109(8):2984–8 Convincingly demonstrates in an animal model that cyclophosphamide can have a permanent teratogenic effect, strengthening the argument for fertility preserving before any treatment is initiated.CrossRefGoogle Scholar
- 15.Aghaie S, Nikzad H, Mahabadi JA, Taghizadeh M, Azami-Tameh A, Taherian A, et al. Protective effect of combined pumpkin seed and ginger extracts on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Anat Sci Int. 2016;91(4):382–90.CrossRefGoogle Scholar
- 23.Returning home from Iraq and Afghanistan: assessment of readjustment needs of veterans, service members, and their families. Mil Med, 2014. 179(10): p. 1053–5.Google Scholar
- 24.Nnamani NS, Janak JC, Hudak SJ, Rivera JC, Lewis EA, Soderdahl DW, et al. Genitourinary injuries and extremity amputation in Operations Enduring Freedom and Iraqi Freedom: early findings from the Trauma Outcomes and Urogenital Health (TOUGH) project. J Trauma Acute Care Surg. 2016;81(5 Suppl 2 Proceedings of the 2015 Military Health System Research Symposium):S95–9.CrossRefGoogle Scholar
- 29.Hall MJ, Levant S, DeFrances CJ. Trends in inpatient hospital deaths: National Hospital Discharge Survey, 2000-2010. NCHS Data Brief. 2013;(118):1–8.Google Scholar
- 31.Ethics Committee of the American Society for Reproductive Medicine. Electronic address, a.a.o. and M. Ethics Committee of the American Society for Reproductive. Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion. Fertil Steril. 2019;111(4):659–63.CrossRefGoogle Scholar
- 33.• Waler NJ, et al. Policy on posthumous sperm retrieval: survey of 75 major academic medical centers. Urology. 2018;113:45–51 A thorough examination of ethical considerations surrounding posthumous sperm retrieval with data from multiple academic centers. Shows that majority hospitals do not have a written policy.CrossRefGoogle Scholar
- 34.Ravitsky V. Posthumous reproduction guidelines in Israel. Hast Cent Rep. 2004;34(2):6–7.Google Scholar